Related Experiment Video
Updated: Aug 1, 2025

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
SH3YL1 Protein Predicts Renal Outcomes in Patients with Type 2 Diabetes
Sang Youb Han1, Seung Hyun Han1, Jung Yeon Ghee2
1Department of Internal Medicine, Inje University, Ilsan-Paik Hospital, Goyang 10380, Republic of Korea.
Abstract:
NADPH oxidase (NOX)-derived oxidative stress is an important factor in renal progression, with NOX4 being the predominant NOX in the kidney. Recently, Src homology 3 (SH3) domain-containing YSC84-like 1 (SH3YL1) was reported to be a regulator of NOX4. In this study, we tested whether the SH3YL1 protein could predict 3-year renal outcomes in patients with type 2 diabetes. A total of 131 patients with type 2 diabetes were enrolled in this study. Renal events were defined as a 15% decline in the estimated glomerular filtration rate (eGFR) from the baseline, the initiation of renal replacement therapy, or death during the 3 years. The levels of the urinary SH3YL1-to-creatinine ratio (USCR) were significantly different among the five stages of chronic kidney disease (CKD) and the three groups, based on albuminuria levels. The USCR levels showed a significant negative correlation with eGFR and a positive correlation with the urinary albumin-to-creatinine ratio (UACR). Plasma SH3YL1 levels were significantly correlated with UACR. The highest tertile group of USCR and plasma SH3YL1 had a significantly lower probability of renal event-free survival. Furthermore, the highest tertile group of USCR showed a significant association with the incidence of renal events after full adjustment: adjusted hazard ratio (4.636: 95% confidence interval, 1.416-15.181, p = 0.011). This study suggests that SH3YL1 is a new diagnostic biomarker for renal outcomes in patients with type 2 diabetes.
Insights
Urinary SH3YL1 protein levels can predict kidney disease progression in patients with type 2 diabetes. Higher urinary SH3YL1-to-creatinine ratio indicates increased risk of renal events.
Area of Science:
- Nephrology
- Diabetology
- Biomarker Discovery
Background:
- Oxidative stress from NADPH oxidase (NOX), particularly NOX4, drives kidney disease progression.
- SH3 domain-containing YSC84-like 1 (SH3YL1) has emerged as a regulator of NOX4.
Purpose of the Study:
- To investigate the potential of SH3YL1 protein as a predictor of 3-year renal outcomes in type 2 diabetes patients.
- To assess the relationship between urinary SH3YL1 levels and markers of kidney function and damage.
Main Methods:
- 131 type 2 diabetes patients were enrolled.
- Renal events defined as a 15% eGFR decline, renal replacement therapy initiation, or death over 3 years.
- Urinary SH3YL1-to-creatinine ratio (USCR) and plasma SH3YL1 levels were measured and correlated with eGFR and UACR.
Main Results:
- USCR levels differed across CKD stages and albuminuria groups.
- USCR negatively correlated with eGFR and positively with UACR; plasma SH3YL1 correlated with UACR.
- Highest USCR tertile associated with significantly lower renal event-free survival and increased renal event incidence (aHR 4.636).
Conclusions:
- SH3YL1 protein, particularly its urinary form, shows promise as a novel diagnostic biomarker for predicting renal outcomes in type 2 diabetes.
- Elevated USCR is linked to poorer kidney function and increased risk of renal events, highlighting its clinical utility.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

